Catalent’s Partner, Passage Bio, Announces New Dedicated Gene Therapy Manufacturing Suite
The dedicated CGMP suite is to be built under strategic partnership with Paragon Gene Therapy to support future clinical and commercial production for Passage Bio’s AAV-delivered gene therapies